Suppr超能文献

鼻中隔成形术与药物治疗对鼻气道阻塞的临床疗效比较:多中心、开放标签、随机对照试验。

Clinical effectiveness of septoplasty versus medical management for nasal airways obstruction: multicentre, open label, randomised controlled trial.

机构信息

Department of Ear, Nose and Throat, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Freeman Hospital, High Heaton, Newcastle upon Tyne, NE7 7DN, UK

Department of Ear, Nose and Throat, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Freeman Hospital, High Heaton, Newcastle upon Tyne, NE7 7DN, UK.

出版信息

BMJ. 2023 Oct 18;383:e075445. doi: 10.1136/bmj-2023-075445.

Abstract

OBJECTIVE

To assess the clinical effectiveness of septoplasty.

DESIGN

Multicentre, randomised controlled trial.

SETTING

17 otolaryngology clinics in the UK's National Health Service.

PARTICIPANTS

378 adults (≥18 years, 67% men) newly referred with symptoms of nasal obstruction associated with septal deviation and at least moderate symptoms of nasal obstruction (score >30 on the Nasal Obstruction and Symptom Evaluation (NOSE) scale).

INTERVENTIONS

Participants were randomised 1:1 to receive either septoplasty (n=188) or defined medical management (n=190, nasal steroid and saline spray for six months), stratified by baseline symptom severity and sex.

MAIN OUTCOME MEASURES

The primary outcome measure was patient reported score on the Sino-Nasal Outcome Test-22 (SNOT-22) at six months, with 9 points defined as the minimal clinically important difference. Secondary outcomes included quality of life and objective nasal airflow measures.

RESULTS

Mean SNOT-22 scores at six months were 19.9 (95% confidence interval 17.0 to 22.7) in the septoplasty arm (n=152, intention-to-treat population) and 39.5 (36.1 to 42.9) in the medical management arm (n=155); an estimated 20.0 points lower (better) for participants randomised to receive septoplasty (95% confidence interval 16.4 to 23.6, P<0.001, adjusted for baseline continuous SNOT-22 score and the stratification variables sex and baseline NOSE severity categories). Greater improvement in SNOT-22 scores was predicted by higher baseline symptom severity scores. Quality of life outcomes and nasal airflow measures (including peak nasal inspiratory flow and absolute inhalational nasal partitioning ratio) improved more in participants in the septoplasty group. Readmission to hospital with bleeding after septoplasty occurred in seven participants (4% of 174 who had septoplasty), and a further 20 participants (12%) required antibiotics for infections.

CONCLUSIONS

Septoplasty is a more effective intervention than a defined medical management regimen with a nasal steroid and saline spray in adults with nasal obstruction associated with a deviated nasal septum.

TRIAL REGISTRATION

ISRCTN Registry ISRCTN16168569.

摘要

目的

评估鼻中隔成形术的临床效果。

设计

多中心、随机对照试验。

地点

英国国民保健署的 17 个耳鼻喉科诊所。

参与者

378 名成年人(≥18 岁,67%为男性),新出现与鼻中隔偏曲相关的鼻塞症状,并至少有中度鼻塞症状(NOSE 量表评分>30)。

干预措施

参与者按基线症状严重程度和性别 1:1 随机分为鼻中隔成形术组(n=188)或规定的药物治疗组(n=190,鼻内类固醇和盐水喷雾治疗 6 个月)。

主要结局测量指标

主要结局测量指标为 6 个月时患者报告的 Sino-Nasal Outcome Test-22(SNOT-22)评分,9 分定义为最小临床重要差异。次要结局包括生活质量和客观鼻腔气流测量。

结果

鼻中隔成形术组(意向治疗人群,n=152)6 个月时 SNOT-22 评分的平均值为 19.9(95%置信区间 17.0 至 22.7),药物治疗组为 39.5(36.1 至 42.9);接受鼻中隔成形术的参与者评分预计低 20.0 分(更好)(95%置信区间 16.4 至 23.6,P<0.001,调整了基线连续 SNOT-22 评分和分层变量性别以及基线 NOSE 严重程度类别)。SNOT-22 评分的改善与较高的基线症状严重程度评分相关。鼻中隔成形术组的生活质量结局和鼻腔气流测量(包括最大鼻吸气流量和绝对吸入性鼻腔分区比)改善更明显。鼻中隔成形术后 7 名参与者(174 名接受鼻中隔成形术的参与者中有 4%)因出血再次住院,另有 20 名参与者(12%)因感染需要抗生素。

结论

鼻中隔成形术是一种比鼻内类固醇和盐水喷雾更有效的治疗方法,在与鼻中隔偏曲相关的鼻塞的成年患者中。

试验注册

ISRCTN 注册处 ISRCTN85504553。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c065/10583133/ed7b6ea27459/cars075445.f1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验